100
Participants
Start Date
March 3, 2020
Primary Completion Date
November 25, 2022
Study Completion Date
November 25, 2022
Meta 18.06 Day and Meta 18.06 Night
5 visits after screening (V0-V4), including questionnaires (V0-V2-V4), salivary tests (V0 \& V4) and calls for antistress advices and adverse events, concomitant medication reporting \& compliance (V1 \& V3)
Placebo Meta 18.06 Day and Placebo Meta 18.06 Night
5 visits after screening (V0-V4), including questionnaires (V0-V2-V4), salivary tests (V0 \& V4) and calls for antistress advices and adverse events, concomitant medication reporting \& compliance (V1 \& V3)
NutrInvest - Institut Pasteur de Lille, Lille
Institut Pasteur de Lille
OTHER